Ch Biotech R And D Co
Ch Biotech R&D Co., a leading player in the biotechnology sector, is headquartered in Taiwan (TW) and operates extensively across Asia. Founded in 2002, the company has established itself as a pioneer in biopharmaceutical research and development, focusing on innovative solutions for healthcare challenges. Specialising in the development of biologics and biosimilars, Ch Biotech R&D Co. is recognised for its commitment to quality and scientific excellence. Their core products include advanced therapeutic proteins and monoclonal antibodies, which are distinguished by their efficacy and safety profiles. With a strong market position, Ch Biotech R&D Co. has achieved significant milestones, including successful collaborations with global pharmaceutical firms. Their dedication to research and development continues to drive advancements in the biotechnology industry, making them a trusted name in biopharmaceutical innovation.
DitchCarbon Score
How does Ch Biotech R And D Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ch Biotech R And D Co's score of 28 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ch Biotech R And D Co's reported carbon emissions
In 2022, Ch Biotech R And D Co reported total carbon emissions of approximately 3,839,712 kg CO2e. This figure includes 437,909.2 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 3,260,882 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity, steam, heating, and cooling. Additionally, Scope 3 emissions accounted for about 138,442.6 kg CO2e, which are indirect emissions not included in Scope 2. Comparatively, in 2021, the company’s total emissions were about 3,995,349 kg CO2e, indicating a reduction of approximately 155,637 kg CO2e year-on-year. This reduction reflects a commitment to improving their environmental impact, although specific reduction targets or initiatives have not been disclosed. Ch Biotech R And D Co's emissions data highlights their ongoing efforts to monitor and manage their carbon footprint, aligning with industry standards for climate accountability. However, the absence of formal reduction targets or climate pledges suggests that further commitments may be necessary to enhance their sustainability profile.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 444,391.6 | 000,000.0 |
| Scope 2 | 3,458,038.1 | 0,000,000 |
| Scope 3 | 90,317.8 | 000,000.0 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ch Biotech R And D Co is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
